Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEPW) Long-Term Investments (2021 - 2025)

Historic Long-Term Investments for Coeptis Therapeutics Holdings (COEPW) over the last 4 years, with Q3 2025 value amounting to $6.9 million.

  • Coeptis Therapeutics Holdings' Long-Term Investments rose 2196.42% to $6.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.9 million, marking a year-over-year increase of 2196.42%. This contributed to the annual value of $5.7 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Coeptis Therapeutics Holdings' Long-Term Investments is $6.9 million, which was up 2196.42% from $6.9 million recorded in Q2 2025.
  • Over the past 5 years, Coeptis Therapeutics Holdings' Long-Term Investments peaked at $75.8 million during Q1 2022, and registered a low of $5.7 million during Q3 2024.
  • Moreover, its 4-year median value for Long-Term Investments was $33.1 million (2022), whereas its average is $39.8 million.
  • In the last 5 years, Coeptis Therapeutics Holdings' Long-Term Investments tumbled by 5645.29% in 2022 and then soared by 2196.42% in 2025.
  • Over the past 4 years, Coeptis Therapeutics Holdings' Long-Term Investments (Quarter) stood at $75.8 million in 2021, then crashed by 56.09% to $33.3 million in 2022, then plummeted by 82.89% to $5.7 million in 2024, then increased by 21.96% to $6.9 million in 2025.
  • Its Long-Term Investments stands at $6.9 million for Q3 2025, versus $6.9 million for Q2 2025 and $6.9 million for Q1 2025.